5 / 2017 / vol. 6
Kosmetologia Estetyczna
487
49.
Z. Shen, T.W. Gao, L. Chen:
Optimal frequency of treatment with the 308-nm excimer
laser for vitiligo on the face and neck
, Photomed Laser Surg, 25, 2007, 418-427.
50.
A. Rao, S. Gupta, A.K. Dinda, A. Sharma, V.K. Sharma, G. Kumar:
Study of clinical, bio-
chemical and immunological factors determining stability of disease in patients with genera-
lized vitiligo undergoing melanocyte transplantation
, Br J Dermatol, 166, 2012, 1230-1236.
51.
W. Löntz, M.J. Olsson, G. Moellmann, A.B. Lerner:
Pigment cell transplantation for
treatment of vitiligo: A progress report
, J Am Acad Dermatol, 30, 1994, 591-597.
52.
R. Falabella:
Surgical treatment of vitiligo: Why, when and how
, J Eur Acad Dermatol
Venereol, 17, 2003, 518-520.
53.
M.D. Njoo, W. Westerhof, J.D. Bos:
A systematic review of autologous transplantation
methods in vitiligo
, Arch Dermatol, 134, 1998, 1543-1549.
54.
S.S. Das, J.S. Pasricha:
Punch grafting as a treatment for residual lesions in vitiligo
, Indian
J Dermatol Venereol Leprol, 58, 1992, 315-319.
55.
K.T. Ashique, F. Kaliyadan:
Long-term follow-up and donor site changes evaluation in
suction blister epidermal grafting done for stable vitiligo: a retrospective study
, Indian J
Dermatol, 60, 2015, 369-372.
56.
H. Bao, W. Hong, L. Fu, X. Wei, G. Qian, A. Xu:
Blister roof grafting, cultured melanocy-
tes transplantation and non-cultured epidermal cell suspension transplantation in treating
stable vitiligo: a mutual self-control study
, J Dermatolog Treat, 26, 2015, 571-574.
57.
J. Li, W.W. Fu, Z.Z. Zheng, Q.Q. Zhang, Y. Xu, L. Fang:
Suction blister epidermal grafting
using a modified suction method in the treatment of stable vitiligo: a retrospective study
,
Dermatol Surg, 37, 2011, 999-1006.
58.
M. Tanioka, Y. Miyachi:
Camouflageforvitiligo
, Dermatologic therapy, 22, 2009, 90-93.
59.
A.M. Oakley:
Rapid repigmentation after depigmentation therapy: vitiligo treated with mo-
nobenzyl ether of hydroquinone
, Australasian Journal of Dermatology, 37, 1996, 96-98.
60.
M.L. Dell’Anna, A. Mastrofrancesco, R. Sala, M. Venturini, et al.:
Antioxidants and
narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial
, Cli-
nical and experimental dermatology, 32, 2007, 631-636.
61.
J.E. Rojas-Urdaneta, A.G. Poleo-Romero:
Evaluation of an antioxidant and mitochon-
dria-stimulating cream formula on the skin of patients with stable common vitiligo
, Inve-
stigacion clinica, 48, 2007, 21-31.
62.
D. Parsad, R. Saini, N. Verma:
Combination of PUVAsol and topical calcipotriol in vitiligo
,
Dermatology, 197, 1998, 167-170.
63.
S.A. Birlea, G.E. Costin, D.A. Norris:
Cellular and molecular mechanisms involved in the
action of vitamin D analogs targeting vitiligo depigmentation
, Current drug targets, 9,
2008, 345-359.
64.
S. Birlea, M. Birlea, D. Cimponeriu, P. Aposto, et al.:
Autoimmune diseases and vitamin
D receptor Apa-I polymorphism are associated with vitiligo in a small inbred Romanian
community
, Acta dermato-venereologica, 86, 2006, 209-214.
65.
D. Parsad, R. Pandhi, A. Juneja:
Effectiveness of oral Ginkgo biloba in treating limited,
slowly spreading vitiligo
, Clinical and experimental dermatology, 28, 2003, 285-287.
66.
O. Szczurko, N. Shear, A. Taddio, H. Boon:
Ginkgobilobaforthetreatmentofvitilgovulgaris:
anopen labelpilotclinicaltrial
, BMC complementary and alternative medicine, 11, 2011, 21.
67.
S.S. Savant:
Therapeutic spot and regional dermabrasion in stable vitiligo, Indian journal
of dermatology
, Venereology and leprology, 62, 1995, 139-145.
68.
M. Vedamurthy, A. Moorthy, S. Samuel:
Successful Treatment of Vitiligo by Needling
with Topical 5 Fluorouracil
, Pigmentary Disorders, 3, 2016, 242.
69.
M.A. Everett:
Protection from sunlight in vitiligo
, Archives of dermatology, 84, 1961,
997-998.
70.
J.R. Porter, A.H. Beuf, A. Lerner, J. Nordlund:
Psychosocial effect of vitiligo: a compa-
rison of vitiligo patients with “normal” control subjects, with psoriasis patients, and with
patients with other pigmentary disorders
, Journal of the American Academy of Der-
matology, 15, 1986, 220-224.
71.
B.A. Salzer, K.U. Schallreuter:
Investigation of the personality structure in patients with
vitiligo and a possible associationwith impaired catecholamine metabolism
, Dermatology,
190, 1995, 109-115.
72.
M.S.K. Al’Abadie, H.J. Senior, S.S. Bleehen, D.J. Gawkrodger:
Neuropeptide and neuro-
nal marker studies in vitiligo
, British Journal of Dermatology, 131, 1994, 160-165.
73.
L. Papadopoulos, C. Walker, L. Anthis: Living with vitiligo:
A controlled investigation
into the effects of group cognitive-behavioural and person-centred therapies
, Dermatolo-
gy and Psychosomatics/Dermatologie und Psychosomatik, 5, 2004, 172-177.
|
|
ŹRODŁA FOTOGRAFII
I.
age=715;epage=721;aulast=Khaitan (dostęp z dnia: 05.08.2017)
II.
-
d=S0365-05962014000500784 (dostęp z dnia: 04.08.2017)
III.
lume=78%3Bissue=1%3Bspage=111%3Bepage=113%3Baulast=De
(dostęp z dnia: 11.03.2017)
IV.
(dostęp z dnia: 11.03.2017)
V.
(dostęp z dnia: 11.03.2017)
